PDCD1 and neoplasm: Rather, chronic immune activation within the inflammatory microenvironment of HGSC, potentially combined with persistent engagement of activating and inhibitory NK cell ligands on tumor or stromal cells, likely contributes to PD‐1 induction, as observed in other pathological contexts [28, 42].